RxDoctor Payments Data

Valentin Antoci, MD

Orthopaedic Surgery · East Providence, RINPI 1093942823

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $163,200 of the $210,306 with a category attached, or 77.6%. Davol Inc. accounts for 89.9% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $166,865, more than ten times the $964 reported in 2019. Among orthopaedic surgery clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$210,306in general payments, 2019–2025

Across 194 payments — averaging $1084.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Davol Inc.$189K
  • Vertex$9K
  • Zimmer Biomet$3K
  • Medacta USA, Inc.$3K
  • Stryker$2K
  • Depuy Synthes Products, Inc.$2K
  • plus $1K from 11 others
$500in research payments, 2019–2025

Across 1 payment — averaging $500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • US Endoscopy$500

What the payments were for

  • Consulting fees$10,3605%
  • Speaking & faculty fees$163,20078%
  • Travel & lodging$31,33415%
  • Food & beverage$5,4123%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$210,306 in reported general payments places this provider in the 95th percentile of 124 orthopaedic surgery providers in Rhode Island.

See all orthopaedic surgery providers in Rhode Island

Medicare billing

Part B allowed, 2024
$259,927
Medicare patients
620
Services billed
1,865

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib202$4,158
Meloxicam527$3,556
Diclofenac Sodium147$2,999
Gabapentin82$976
Duloxetine Hcl29$786
Oxycodone Hcl89$704
Methylprednisolone82$678
Amoxicillin147$300
Tizanidine Hcl24$253
Ibuprofen15$201
Cyclobenzaprine Hcl17$155
Ondansetron Hcl18$143
Tramadol Hcl19$96
Clindamycin Hcl18$54

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in East Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →